Locations:
SearchAdvertisement
Long-awaited efficacy against disability progression appears to be at hand
MRI classifier identifies a subset of patients with disease marked by cortical atrophy, not demyelination
Findings challenge dogma that microglia are exclusively destructive regardless of location in brain
New review distills insights from studies over the past decade
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Single-arm, open-label study offers proof of concept for MSC-NTF cells
Panel outlines research priorities around a promising alternative to imaging markers
Three criteria for finding an effective treatment for neurodegeneration
Paves way for phase 3 testing of novel treatment approach
Advertisement
Advertisement